CorMedix Inc.
CRMD
$10.32
$0.545.52%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 214.30M | 121.48M | 82.55M | 43.47M | 12.26M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 214.30M | 121.48M | 82.55M | 43.47M | 12.26M |
| Cost of Revenue | 12.20M | 5.27M | 3.92M | 3.14M | 1.96M |
| Gross Profit | 202.10M | 116.22M | 78.64M | 40.33M | 10.30M |
| SG&A Expenses | 82.06M | 58.76M | 57.81M | 58.70M | 56.70M |
| Depreciation & Amortization | 3.63M | 51.90K | 51.90K | 51.90K | 51.90K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 110.35M | 72.17M | 68.08M | 65.83M | 63.22M |
| Operating Income | 103.95M | 49.32M | 14.47M | -22.36M | -50.96M |
| Income Before Tax | 107.03M | 51.68M | 17.18M | -19.32M | -47.54M |
| Income Tax Expenses | -55.47M | 521.50K | 0.00 | -1.39M | -1.39M |
| Earnings from Continuing Operations | 162.50 | 51.16 | 17.18 | -17.93 | -46.15 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 162.50M | 51.16M | 17.18M | -17.93M | -46.15M |
| EBIT | 103.95M | 49.32M | 14.47M | -22.36M | -50.96M |
| EBITDA | 108.20M | 49.85M | 14.92M | -22.05M | -50.77M |
| EPS Basic | 2.26 | 0.78 | 0.24 | -0.33 | -0.80 |
| Normalized Basic EPS | 0.95 | 0.49 | 0.15 | -0.22 | -0.52 |
| EPS Diluted | 2.06 | 0.75 | 0.22 | -0.33 | -0.81 |
| Normalized Diluted EPS | 0.88 | 0.47 | 0.14 | -0.22 | -0.52 |
| Average Basic Shares Outstanding | 270.61M | 253.51M | 243.20M | 235.46M | 231.34M |
| Average Diluted Shares Outstanding | 288.62M | 261.23M | 246.93M | 235.46M | 231.34M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |